Found 5 matching trials
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PHASE1RATIONALE: Vaccines made from peptides may help the body build an effective...
Location
Addenbrooke's Hospital
Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
PHASE1BACKGROUND: Active immunotherapy of cancer is based on the premise that the...
Location
Neuro-Oncology Branch of the National Cancer Institute, National Institutes of Health
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
PHASE1This is a pilot, randomized, two arm neoadjuvant vaccine study in human leu...
Location
University of California
Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
PHASE1Monocentric randomized phase I/II trial, including 24 patients diagnosed wi...
Location
University Hospitals of Geneva
Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma
PHASE1RATIONALE : IMA 950 is multi tumour-associated peptides (TUMAPs) vaccine, t...
Location
Geneva University Hospitals, Centre of Oncology